What is HD?
HD operates as a specialized medtech and healthcare solutions provider headquartered in Bangkok, Thailand. The company occupies a strategic position within the regional health-tech ecosystem, focusing on the digitization of healthcare services to improve patient outcomes and operational efficiency for providers. By integrating advanced technology into the healthcare value chain, HD addresses the complexities of the Southeast Asian market, where demand for scalable, tech-enabled medical solutions is rising rapidly. The company's business model is designed to bridge the gap between traditional medical services and modern digital infrastructure, positioning it as a key player in the ongoing transformation of the regional healthcare landscape.
How much funding has HD raised?
HD has raised a total of $11.6M across 2 funding rounds:
Angel/Seed
$6M
Series A
$5.6M
Angel/Seed (2023): $6M with participation from AC Ventures, Partech International, and iSeed
Series A (2024): $5.6M led by SBI Ven Capital, FEBE Ventures, and M Venture Partners
Key Investors in HD
AC Ventures
ACV Capital is a growth equity investment firm that focuses on high-growth, technology-enabled businesses across Southeast Asia, providing strategic guidance and operational expertise.
Partech International
A global investment firm that brings together capital, operational experience, and strategic support for entrepreneurs at seed, venture, and growth stages across multiple continents.
SBI Ven Capital
A prominent private equity and private credit firm focusing on investments in the financial services and technology sectors, with a specific interest in fintech and health tech.
What's next for HD?
With the successful closure of its latest funding round, HD is expected to prioritize the scaling of its core technology platform and the expansion of its service network. The strategic focus will likely shift toward enhancing enterprise-grade features, deepening market penetration in Thailand, and potentially exploring adjacent markets within the Southeast Asian corridor. As the company matures, the emphasis will remain on maintaining high-growth metrics while optimizing its healthcare delivery model to ensure long-term sustainability and competitive advantage in an increasingly crowded digital health sector.
See full HD company page
